Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Nicotinamide and WLDS Act Together to Prevent Neurodegeneration in Glaucoma.

Williams PA, Harder JM, Foxworth NE, Cardozo BH, Cochran KE, John SWM.

Front Neurosci. 2017 Apr 25;11:232. doi: 10.3389/fnins.2017.00232. eCollection 2017.

2.

Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective.

Harder JM, Braine CE, Williams PA, Zhu X, MacNicoll KH, Sousa GL, Buchanan RA, Smith RS, Libby RT, Howell GR, John SWM.

Proc Natl Acad Sci U S A. 2017 May 9;114(19):E3839-E3848. doi: 10.1073/pnas.1608769114. Epub 2017 Apr 26.

3.

GlyCAM1 negatively regulates monocyte entry into the optic nerve head and contributes to radiation-based protection in glaucoma.

Williams PA, Braine CE, Foxworth NE, Cochran KE, John SWM.

J Neuroinflammation. 2017 Apr 26;14(1):93. doi: 10.1186/s12974-017-0868-8.

4.

Metabolic Vulnerability in the Neurodegenerative Disease Glaucoma.

Inman DM, Harun-Or-Rashid M.

Front Neurosci. 2017 Mar 30;11:146. doi: 10.3389/fnins.2017.00146. eCollection 2017. Review.

5.

Regenerative Responses and Axon Pathfinding of Retinal Ganglion Cells in Chronically Injured Mice.

Yungher BJ, Ribeiro M, Park KK.

Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1743-1750. doi: 10.1167/iovs.16-19873.

6.

BAX to basics: How the BCL2 gene family controls the death of retinal ganglion cells.

Maes ME, Schlamp CL, Nickells RW.

Prog Retin Eye Res. 2017 Mar;57:1-25. doi: 10.1016/j.preteyeres.2017.01.002. Epub 2017 Jan 4. Review.

PMID:
28064040
7.

Loss of Fractalkine Signaling Exacerbates Axon Transport Dysfunction in a Chronic Model of Glaucoma.

Breen KT, Anderson SR, Steele MR, Calkins DJ, Bosco A, Vetter ML.

Front Neurosci. 2016 Nov 24;10:526. eCollection 2016.

8.

Overexpression of Soluble Fas Ligand following Adeno-Associated Virus Gene Therapy Prevents Retinal Ganglion Cell Death in Chronic and Acute Murine Models of Glaucoma.

Krishnan A, Fei F, Jones A, Busto P, Marshak-Rothstein A, Ksander BR, Gregory-Ksander M.

J Immunol. 2016 Dec 15;197(12):4626-4638. Epub 2016 Nov 14.

PMID:
27849168
9.

Mitochondrial pathogenic mechanism and degradation in optineurin E50K mutation-mediated retinal ganglion cell degeneration.

Shim MS, Takihara Y, Kim KY, Iwata T, Yue BY, Inatani M, Weinreb RN, Perkins GA, Ju WK.

Sci Rep. 2016 Sep 22;6:33830. doi: 10.1038/srep33830.

10.

Evaluating retinal ganglion cell loss and dysfunction.

Mead B, Tomarev S.

Exp Eye Res. 2016 Oct;151:96-106. doi: 10.1016/j.exer.2016.08.006. Epub 2016 Aug 12. Review.

PMID:
27523467
11.

Intracellular disulfide reduction by phosphine-borane complexes: Mechanism of action for neuroprotection.

Niemuth NJ, Thompson AF, Crowe ME, Lieven CJ, Levin LA.

Neurochem Int. 2016 Oct;99:24-32. doi: 10.1016/j.neuint.2016.05.014. Epub 2016 Jun 2.

PMID:
27264910
12.

Automated Axon Counting in Rodent Optic Nerve Sections with AxonJ.

Zarei K, Scheetz TE, Christopher M, Miller K, Hedberg-Buenz A, Tandon A, Anderson MG, Fingert JH, Abràmoff MD.

Sci Rep. 2016 May 26;6:26559. doi: 10.1038/srep26559.

13.

Rescue of Glaucomatous Neurodegeneration by Differentially Modulating Neuronal Endoplasmic Reticulum Stress Molecules.

Yang L, Li S, Miao L, Huang H, Liang F, Teng X, Xu L, Wang Q, Xiao W, Ridder WH 3rd, Ferguson TA, Chen DF, Kaufman RJ, Hu Y.

J Neurosci. 2016 May 25;36(21):5891-903. doi: 10.1523/JNEUROSCI.3709-15.2016.

14.

Retinal glial responses to optic nerve crush are attenuated in Bax-deficient mice and modulated by purinergic signaling pathways.

Mac Nair CE, Schlamp CL, Montgomery AD, Shestopalov VI, Nickells RW.

J Neuroinflammation. 2016 Apr 28;13(1):93. doi: 10.1186/s12974-016-0558-y.

15.

Persistence of intact retinal ganglion cell terminals after axonal transport loss in the DBA/2J mouse model of glaucoma.

Smith MA, Xia CZ, Dengler-Crish CM, Fening KM, Inman DM, Schofield BR, Crish SD.

J Comp Neurol. 2016 Dec 1;524(17):3503-3517. doi: 10.1002/cne.24012. Epub 2016 May 3.

PMID:
27072596
16.

Intravitreal administration of multipotent mesenchymal stromal cells triggers a cytoprotective microenvironment in the retina of diabetic mice.

Ezquer M, Urzua CA, Montecino S, Leal K, Conget P, Ezquer F.

Stem Cell Res Ther. 2016 Mar 16;7:42. doi: 10.1186/s13287-016-0299-y.

17.

Glial coverage in the optic nerve expands in proportion to optic axon loss in chronic mouse glaucoma.

Bosco A, Breen KT, Anderson SR, Steele MR, Calkins DJ, Vetter ML.

Exp Eye Res. 2016 Sep;150:34-43. doi: 10.1016/j.exer.2016.01.014. Epub 2016 Feb 3.

PMID:
26851485
18.

Analysis of functional polymorphisms in apoptosis-related genes in primary open angle glaucoma.

Lindner E, Glatz W, Schwab C, El-Shabrawi Y, Mossböck G.

Mol Vis. 2015 Dec 30;21:1340-4. eCollection 2015.

19.

Novel axon projection after stress and degeneration in the Dscam mutant retina.

Fernandes KA, Bloomsburg SJ, Miller CJ, Billingslea SA, Merrill MM, Burgess RW, Libby RT, Fuerst PG.

Mol Cell Neurosci. 2016 Mar;71:1-12. doi: 10.1016/j.mcn.2015.12.003. Epub 2015 Dec 10.

20.

Quantitative measurement of retinal ganglion cell populations via histology-based random forest classification.

Hedberg-Buenz A, Christopher MA, Lewis CJ, Fernandes KA, Dutca LM, Wang K, Scheetz TE, Abràmoff MD, Libby RT, Garvin MK, Anderson MG.

Exp Eye Res. 2016 May;146:370-85. doi: 10.1016/j.exer.2015.09.011. Epub 2015 Oct 22.

Supplemental Content

Support Center